ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89 | -15.2% | 28,284 | +33.6% | 0.00% | 0.0% |
| Q2 2023 | $105 | +18.0% | 21,175 | +16.9% | 0.00% | 0.0% |
| Q1 2023 | $89 | +7.2% | 18,110 | +37.0% | 0.00% | 0.0% |
| Q4 2022 | $83 | -100.0% | 13,220 | -23.5% | 0.00% | -60.0% |
| Q3 2022 | $186,000 | +195.2% | 17,272 | +211.8% | 0.01% | +150.0% |
| Q2 2022 | $63,000 | -4.5% | 5,540 | -23.9% | 0.00% | 0.0% |
| Q1 2022 | $66,000 | -20.5% | 7,276 | +123.5% | 0.00% | 0.0% |
| Q3 2021 | $83,000 | 0.0% | 3,255 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $83,000 | -25.9% | 3,220 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $112,000 | +38.3% | 3,180 | -1.9% | 0.00% | 0.0% |
| Q4 2020 | $81,000 | +84.1% | 3,240 | +172.7% | 0.00% | 0.0% |
| Q3 2020 | $44,000 | – | 1,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |